COMMUNIQUÉS West-GlobeNewswire

-
Radius Health Announces Latest 2019 Medicare Part D Coverage for TYMLOS® (abaloparatide) Injection
03/10/2018 -
Precipio Launches HemeScreen™, a Disruptive, Proprietary Molecular Test for Hematologic Cancers
03/10/2018 -
Results from a large observational study combining the National Early Warning Score (NEWS) with suPAR documents that suPARnostic® improves risk stratification in acute medical patients
03/10/2018 -
Biogen to Present Data from its Neurology Pipeline at the 2018 International Congress of Parkinson’s Disease and Movement Disorders (MDS)
03/10/2018 -
Cellular Biomedicine Group Obtained NCI Patent License for Next Generation Neoantigen-Reactive Tumor Infiltrating Lymphocyte (TIL) Technology to Treat Solid Tumors
03/10/2018 -
ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center
03/10/2018 -
Myriad Genetics Announces Four Presentations at the 2018 American College of Rheumatology Annual Meeting
03/10/2018 -
Oasmia Presents Positive Efficacy and Safety Data for Doxophos Vet in Treatment of Naïve Dogs with Lymphoma
03/10/2018 -
Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products
03/10/2018 -
Summit Highlights Phase 3-Ready Precision Antibiotic Ridinilazole at IDWeek 2018
03/10/2018 -
Aclaris Therapeutics Announces Poster Presentations at 2018 American Society for Dermatologic Surgery Annual Meeting and Fall Clinical Dermatology Conference
03/10/2018 -
Optinose to Highlight Data at Two Upcoming Scientific Meetings
03/10/2018 -
Neon Therapeutics to Present Data from Ongoing Phase 1b NT-001 Clinical Trial at the European Society for Medical Oncology 2018 Congress
03/10/2018 -
T2 Biosystems Announces Customer Presentations at October Conferences
03/10/2018 -
Capricor Therapeutics to Present at 2018 Cell & Gene Meeting on the Mesa
03/10/2018 -
BeyondSpring to Present Clinical Trial Data at Three Upcoming Scientific Conferences
03/10/2018 -
Tetra Bio-Pharma Moves PPP001 Closer to Commercial Manufacturing with the Issuance of a Drug Establishment License to Ford’s Pharmacy
03/10/2018 -
TRU NIAGEN® PRO to be Featured at the North American Menopause Society (NAMS) Annual Meeting
03/10/2018 -
BrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In-Class Strategy in ALS
03/10/2018
Pages